<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>184 cases of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> were treated by various <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>25.1% of the 35 patients with moderately severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> showed a hematological response to bolus <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> m PSL treatment </plain></SENT>
<SENT sid="2" pm="."><plain>9.6% of 73, 16.9% of 65 and 42.9% of 14 cases with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> responded to m PSL, anti-lymphocyte globulin and anti-thymocyte globulin treatment, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>There was no difference in the survival of these severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients, however, which were prolonged invariably by treatment with each of these <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>No correlation was observed between the in vitro increase of hematopoietic cell colony growth of the patient's bone marrow and clinical response to the <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> </plain></SENT>
</text></document>